EP1094863A4 - Verfahren zur behandlung von neurologischen verletzungen und erkrankungen - Google Patents

Verfahren zur behandlung von neurologischen verletzungen und erkrankungen

Info

Publication number
EP1094863A4
EP1094863A4 EP99939649A EP99939649A EP1094863A4 EP 1094863 A4 EP1094863 A4 EP 1094863A4 EP 99939649 A EP99939649 A EP 99939649A EP 99939649 A EP99939649 A EP 99939649A EP 1094863 A4 EP1094863 A4 EP 1094863A4
Authority
EP
European Patent Office
Prior art keywords
disorders
methods
treating neurological
neurological injuries
injuries
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99939649A
Other languages
English (en)
French (fr)
Other versions
EP1094863A2 (de
Inventor
Mark Marchionni
Michael Jarpe
Ted Ebendal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cenes Pharmaceuticals Inc
Original Assignee
Cambridge Neuroscience Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cambridge Neuroscience Inc filed Critical Cambridge Neuroscience Inc
Publication of EP1094863A2 publication Critical patent/EP1094863A2/de
Publication of EP1094863A4 publication Critical patent/EP1094863A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/48—Nerve growth factor [NGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Hospice & Palliative Care (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP99939649A 1998-07-06 1999-07-02 Verfahren zur behandlung von neurologischen verletzungen und erkrankungen Withdrawn EP1094863A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9179198P 1998-07-06 1998-07-06
US91791P 1998-07-06
PCT/US1999/015106 WO2000001440A2 (en) 1998-07-06 1999-07-02 Methods for treating neurological injuries and disorders

Publications (2)

Publication Number Publication Date
EP1094863A2 EP1094863A2 (de) 2001-05-02
EP1094863A4 true EP1094863A4 (de) 2005-02-02

Family

ID=22229675

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99939649A Withdrawn EP1094863A4 (de) 1998-07-06 1999-07-02 Verfahren zur behandlung von neurologischen verletzungen und erkrankungen

Country Status (6)

Country Link
EP (1) EP1094863A4 (de)
JP (1) JP2002519394A (de)
KR (1) KR20010079503A (de)
AU (1) AU771437B2 (de)
CA (1) CA2336718A1 (de)
WO (1) WO2000001440A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1439191B1 (de) * 2004-01-19 2006-04-05 Ares Trading S.A. Verfahren zur Reinigung von in Bakterien exprimierten Proteinen
WO2008133141A1 (ja) * 2007-04-24 2008-11-06 Toyo Boseki Kabushiki Kaisha オスモチン組換えタンパク質およびその製造方法、並びにその利用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992000382A1 (en) * 1990-06-15 1992-01-09 Carnegie Institution Of Washington Gdf-1

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5652118A (en) * 1991-03-11 1997-07-29 Creative Biomolecules, Inc. Nucleic acid encoding a novel morphogenic protein, OP-3
US5635372A (en) * 1995-05-18 1997-06-03 Genetics Institute, Inc. BMP-15 compositions
US5767252A (en) * 1996-04-08 1998-06-16 The Johns Hopkins University School Of Medicine Neuronal cell growth factor, Narp

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992000382A1 (en) * 1990-06-15 1992-01-09 Carnegie Institution Of Washington Gdf-1

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
EBENDAL T ET AL: "MINI-REVIEW BONE MORPHOGENETIC PROTEINS AND THEIR RECEPTORS: POTENTIAL FUNCTIONS IN THE BRAIN", JOURNAL OF NEUROSCIENCE RESEARCH, WILEY-LISS, US, vol. 51, no. 2, 5 January 1998 (1998-01-05), pages 139 - 146, XP000952988, ISSN: 0360-4012 *
See also references of WO0001440A3 *

Also Published As

Publication number Publication date
WO2000001440A2 (en) 2000-01-13
KR20010079503A (ko) 2001-08-22
WO2000001440A3 (en) 2000-04-20
JP2002519394A (ja) 2002-07-02
CA2336718A1 (en) 2000-01-13
AU5390299A (en) 2000-01-24
AU771437B2 (en) 2004-03-25
EP1094863A2 (de) 2001-05-02

Similar Documents

Publication Publication Date Title
PL337888A1 (en) Imidazoprimidines and imidazopyridines for use in treating neurological disorders
HUP0001237A3 (en) Methods for treating vascular disorders
IL134289A0 (en) Methods for treating neurological deficits
IL126203A0 (en) Method for treating pain
EP0906104A4 (de) Schmerzbehandlungsverfahren
EP1200086A4 (de) Methoden zur behandlung oder vorbeugung von schmerzen und angstzuständen
EP0889888A4 (de) Behandlung von verletzungen des zentralen nervensystems
EP0889887A4 (de) Behandlung von verletzungen des zentralen nervensystems
HUP0200495A2 (en) Method of treating eating disorders
HUP0003964A2 (en) Methods for treating thrombotic disorders
PL324313A1 (en) 10-axcyloxy 10,11-dihydrobenz/b,f/azepin-5-carboxyamides useful in treating nervous system disorders
IL141263A0 (en) Methods for treatment of neurological disorders
PL339425A1 (en) Treatment of behavioural disorders
AU4868599A (en) Composition for and method of treating neurological disorders
AU1833699A (en) Device and method for treating parkinson's disease
GB9908175D0 (en) Method of treating neurological disorders
IL145696A0 (en) Method for the treatment of neurological or neuropsychiatric disorders
EP1207874A4 (de) Verfahren zur behandlung der proliferativen erkrankungen
ZA951088B (en) Use of substituted arylcyclobutylalkylamine compounds in the treatment of seizures neurological disorders and neurological damage
IL126064A0 (en) Method for treating pain
PL345110A1 (en) Aza-heterocyclic compounds used to treat neurological disorders and hair loss
PL332313A1 (en) Application of benzopyranoles in treatment of neurological disorders
AU5298699A (en) Dnazymes and methods for treating hpv-related disorders
PL332821A1 (en) Pyrazolydinones for treating potency disorders
EP1094863A4 (de) Verfahren zur behandlung von neurologischen verletzungen und erkrankungen

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010202

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20041216

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 61K 48/00 B

Ipc: 7A 61K 38/18 B

Ipc: 7C 07K 14/48 B

Ipc: 7A 61N 1/00 A

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20050622